These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21670214)

  • 21. A single amino acid residue constitutes the third dimerization domain essential for the assembly and function of the tetrameric polycystin-2 (TRPP2) channel.
    Feng S; Rodat-Despoix L; Delmas P; Ong AC
    J Biol Chem; 2011 May; 286(21):18994-9000. PubMed ID: 21474446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.
    Brill AL; Ehrlich BE
    Cell Signal; 2020 Feb; 66():109490. PubMed ID: 31805375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of primary cilia increases polycystin-2 and TRPV4 and the appearance of a nonselective cation channel in the mouse cortical collecting duct.
    Saigusa T; Yue Q; Bunni MA; Bell PD; Eaton DC
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F632-F637. PubMed ID: 31313950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardin-Related Transcription Factor Mediates Epithelial Fibrogenesis in Polycystic Kidney Disease.
    Lichner Z; Ding M; Khare T; Dan Q; Benitez R; Praszner M; Song X; Saleeb R; Hinz B; Pei Y; Szászi K; Kapus A
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and function of polycystins: insights into polycystic kidney disease.
    Douguet D; Patel A; Honoré E
    Nat Rev Nephrol; 2019 Jul; 15(7):412-422. PubMed ID: 30948841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease.
    Leuenroth SJ; Okuhara D; Shotwell JD; Markowitz GS; Yu Z; Somlo S; Crews CM
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4389-94. PubMed ID: 17360534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease.
    Vassilev PM; Guo L; Chen XZ; Segal Y; Peng JB; Basora N; Babakhanlou H; Cruger G; Kanazirska M; Ye Cp ; Brown EM; Hediger MA; Zhou J
    Biochem Biophys Res Commun; 2001 Mar; 282(1):341-50. PubMed ID: 11264013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
    Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
    Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD.
    Parnell SC; Magenheimer BS; Maser RL; Pavlov TS; Havens MA; Hastings ML; Jackson SF; Ward CJ; Peterson KR; Staruschenko A; Calvet JP
    Hum Mol Genet; 2018 Oct; 27(19):3313-3324. PubMed ID: 29931260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines.
    Papavassiliou KA; Zoi I; Gargalionis AN; Koutsilieris M
    J Cell Mol Med; 2019 Sep; 23(9):6215-6227. PubMed ID: 31251475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
    Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Properties of TRPV4 Mutant Channels Present in Polycystic Kidney Disease Patients.
    Hernández-Vega AM; Llorente I; Sánchez-Hernández R; Segura Y; Tusié-Luna T; Morales-Buenrostro LE; García-Villegas R; Islas LD; Rosenbaum T
    Function (Oxf); 2024 Sep; 5(5):. PubMed ID: 38984987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.
    Natoli TA; Gareski TC; Dackowski WR; Smith L; Bukanov NO; Russo RJ; Husson H; Matthews D; Piepenhagen P; Ibraghimov-Beskrovnaya O
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F73-83. PubMed ID: 17928412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR signaling in polycystic kidney disease.
    Ibraghimov-Beskrovnaya O; Natoli TA
    Trends Mol Med; 2011 Nov; 17(11):625-33. PubMed ID: 21775207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy.
    Harris PC; Torres VE
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):456-63. PubMed ID: 16775462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.
    Magistroni R; Mangolini A; Guzzo S; Testa F; Rapanà MR; Mignani R; Russo G; di Virgilio F; Aguiari G
    BMC Nephrol; 2019 Sep; 20(1):355. PubMed ID: 31514750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of oriented cell division does not initiate cyst formation.
    Nishio S; Tian X; Gallagher AR; Yu Z; Patel V; Igarashi P; Somlo S
    J Am Soc Nephrol; 2010 Feb; 21(2):295-302. PubMed ID: 19959710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
    Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
    Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciliary exclusion of Polycystin-2 promotes kidney cystogenesis in an autosomal dominant polycystic kidney disease model.
    Walker RV; Keynton JL; Grimes DT; Sreekumar V; Williams DJ; Esapa C; Wu D; Knight MM; Norris DP
    Nat Commun; 2019 Sep; 10(1):4072. PubMed ID: 31492868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.
    Bastos AP; Onuchic LF
    Braz J Med Biol Res; 2011 Jul; 44(7):606-17. PubMed ID: 21625823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.